J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thullier, P.
Right arrow Articles by Lafaye, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thullier, P.
Right arrow Articles by Lafaye, P.
Agricola
Right arrow Articles by Thullier, P.
Right arrow Articles by Lafaye, P.
Journal of General Virology (2001), 82, 1885-1892.
© 2001 Society for General Microbiology


Animal: RNA Viruses

Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism

Philippe Thullier1,4, Caroline Demangel1, Hugues Bedouelle2, Françoise Mégret3, Alain Jouan4, Vincent Deubel3, Jean-Claude Mazié1 and Pierre Lafaye1

Laboratoire d’Ingénierie des Anticorps1, Unité de Biochimie Cellulaire2 and Unité des Arbovirus et Virus des Fièvres Hémorragiques3, Institut Pasteur, Paris, France
Département de Biologie des Agents Transmissibles, Centre de Recherche du Service de Santé des Armées, BP 87, 38702 La Tronche Cedex, France4

Author for correspondence: Philippe Thullier (at Centre de Recherche du Service de Santé des Armées). Fax +33 4 76 63 69 17. e-mail pthullier{at}yahoo.com

Dengue virus infections are a growing public health concern and strategies to control the spread of the virus are urgently needed. The murine monoclonal antibody 4E11 might be of interest, since it neutralizes dengue viruses of all serotypes by binding to the 296–400 segment of the major dengue virus envelope glycoprotein (DE). When phage-displayed peptide libraries were screened by affinity for 4E11, phage clone C1 was selected with a 50% frequency. C1 shared three of nine residues with DE306–314 and showed significant reactivity to 4E11 in ELISA. C1-induced antibodies cross-reacted with DE296–400 in mice, suggesting that it was a structural equivalent of the native epitope of 4E11 on DE. Accordingly, 4E11 bound to the DE306–314 synthetic peptide and this reaction was inhibited by DE296–400. Moreover, DE306–314 could block dengue virus infection of target cells in an in vitro assay. A three-dimensional model of DE revealed that the three amino acids shared by DE296–400 and C1 were exposed to the solvent and suggested that most of the amino acids comprising the 4E11 epitope were located in the DE306–314 region. Since 4E11 blocked the binding of DE296–400 to heparin, which is a highly sulfated heparan sulfate (HSHS) molecule, 4E11 may act by neutralizing the interaction of DE306–314 with target cell-displayed HSHS. Our data suggest that the DE306–314 segment is critical for the infectivity of all dengue virus serotypes and that molecules that block the binding of DE306–314 to HSHS may be antiviral reagents of therapeutic interest.




This article has been cited by other articles:


Home page
J. Virol.Home page
G. D. Gromowski, N. D. Barrett, and A. D. T. Barrett
Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus
J. Virol., September 1, 2008; 82(17): 8828 - 8837.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
J. Abd-Jamil, C.-Y. Cheah, and S. AbuBakar
Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites
Protein Eng. Des. Sel., July 30, 2008; (2008) gzn041v1.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Sukupolvi-Petty, S. K. Austin, W. E. Purtha, T. Oliphant, G. E. Nybakken, J. J. Schlesinger, J. T. Roehrig, G. D. Gromowski, A. D. Barrett, D. H. Fremont, et al.
Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes
J. Virol., December 1, 2007; 81(23): 12816 - 12826.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
O. Lisova, F. Hardy, V. Petit, and H. Bedouelle
Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus
J. Gen. Virol., September 1, 2007; 88(9): 2387 - 2397.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
E. Lee, P. J. Wright, A. Davidson, and M. Lobigs
Virulence attenuation of Dengue virus due to augmented glycosaminoglycan-binding affinity and restriction in extraneural dissemination.
J. Gen. Virol., October 1, 2006; 87(Pt 10): 2791 - 2801.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
C. Aoki, K. I.P.J. Hidari, S. Itonori, A. Yamada, N. Takahashi, T. Kasama, F. Hasebe, M. A. Islam, K. Hatano, K. Matsuoka, et al.
Identification and characterization of carbohydrate molecules in Mammalian cells recognized by dengue virus type 2.
J. Biochem., March 1, 2006; 139(3): 607 - 614.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. Laffly, L. Danjou, F. Condemine, D. Vidal, E. Drouet, M.-P. Lefranc, C. Bottex, and P. Thullier
Selection of a Macaque Fab with Framework Regions Like Those in Humans, High Affinity, and Ability To Neutralize the Protective Antigen (PA) of Bacillus anthracis by Binding to the Segment of PA between Residues 686 and 694
Antimicrob. Agents Chemother., August 1, 2005; 49(8): 3414 - 3420.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Modis, S. Ogata, D. Clements, and S. C. Harrison
Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein
J. Virol., January 15, 2005; 79(2): 1223 - 1231.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J.-h. Chu and M.-L. Ng
Interaction of West Nile Virus with {alpha}v{beta}3 Integrin Mediates Virus Entry into Cells
J. Biol. Chem., December 24, 2004; 279(52): 54533 - 54541.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. P. Goncalvez, R. H. Purcell, and C.-J. Lai
Epitope Determinants of a Chimpanzee Fab Antibody That Efficiently Cross-Neutralizes Dengue Type 1 and Type 2 Viruses Map to Inside and in Close Proximity to Fusion Loop of the Dengue Type 2 Virus Envelope Glycoprotein
J. Virol., December 1, 2004; 78(23): 12919 - 12928.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. J. H. Chu and M. L. Ng
Infectious Entry of West Nile Virus Occurs through a Clathrin-Mediated Endocytic Pathway
J. Virol., October 1, 2004; 78(19): 10543 - 10555.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. R. Holbrook, R. E. Shope, and A. D. T. Barrett
Use of Recombinant E Protein Domain III-Based Enzyme-Linked Immunosorbent Assays for Differentiation of Tick-Borne Encephalitis Serocomplex Flaviviruses from Mosquito-Borne Flaviviruses
J. Clin. Microbiol., September 1, 2004; 42(9): 4101 - 4110.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. W. C. Beasley and A. D. T. Barrett
Identification of Neutralizing Epitopes within Structural Domain III of the West Nile Virus Envelope Protein
J. Virol., November 13, 2002; 76(24): 13097 - 13100.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
V. DEUBEL, L. FIETTE, P. GOUNON, M. T. DROUET, H. KHUN, M. HUERRE, C. BANET, M. MALKINSON, and P. DESPRES
Variations in Biological Features of West Nile Viruses
Ann. N.Y. Acad. Sci., December 1, 2001; 951(1): 195 - 206.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2001 by the Society for General Microbiology.